PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,193,000 | -48.6% | 103,996 | +12.3% | 0.00% | -50.0% |
Q3 2016 | $6,208,000 | +127.7% | 92,595 | +1.2% | 0.01% | +166.7% |
Q2 2016 | $2,726,000 | +873.6% | 91,504 | +859.1% | 0.00% | – |
Q1 2016 | $280,000 | -70.7% | 9,541 | -21.6% | 0.00% | -100.0% |
Q4 2015 | $955,000 | -15.9% | 12,175 | -19.2% | 0.00% | -50.0% |
Q3 2015 | $1,136,000 | -62.8% | 15,074 | -42.4% | 0.00% | -50.0% |
Q2 2015 | $3,055,000 | -83.1% | 26,167 | -65.9% | 0.00% | -83.3% |
Q1 2015 | $18,092,000 | +27.8% | 76,626 | +2.4% | 0.02% | +26.3% |
Q4 2014 | $14,156,000 | -22.2% | 74,794 | -1.9% | 0.02% | -24.0% |
Q3 2014 | $18,198,000 | +255.2% | 76,278 | -1.7% | 0.02% | +257.1% |
Q2 2014 | $5,124,000 | -23.4% | 77,634 | +20.9% | 0.01% | -30.0% |
Q1 2014 | $6,688,000 | +6.2% | 64,220 | +5.5% | 0.01% | +11.1% |
Q4 2013 | $6,300,000 | +88.2% | 60,856 | -2.5% | 0.01% | +50.0% |
Q3 2013 | $3,348,000 | +29.6% | 62,402 | +7.1% | 0.01% | +20.0% |
Q2 2013 | $2,584,000 | – | 58,238 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |